A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

Memorial Sloan Kettering Cancer Ctr, New York

Staten Island Unversity Hospital, Staten Island

Westchester County Medical Center, Valhalla

South Shore Hem-Onc Assoc. PA, Rockville Centre

VAMC Northport, Northport

Buffalo Medical Group PC, Williamsville

Roswell Park Cancer Institute, Buffalo

University of Rochester Cancer Center, Rochester

Western Pennsylvania Cancer Institute, Pittsburgh

Lancaster Cancer Center LTD, Lancaster

Medical Oncology Associates, Kingston

MCP Hahnemann University, Philadelphia

Northwestern Carolina Hematology Oncology PA, Hickory

Southeast Florida Hematology-Oncology, Fort Lauderdale

Florida Cancer Specialists, Fort Myers

Jackson Oncology Associates PLLC, Jackson

Oncology/Hematology Care Inc, Cincinnati

Beaumont Cancer Center, Royal Oak

Oncology Associates, Cedar Rapids

SMDC Health Systems, Duluth

Mayo Clinic, Rochester

Northwest Medical Specialists, Arlington Heights

Hematology Oncology Consultants Inc, St Louis

Texas Oncology PA-BMT Center, Dallas

InterMountain Hematology/Oncology, Salt Lake City

Central Utah Medical Clinic, Provo

Southern Nevada Cancer Research Foundation, Las Vegas

Comprehensive Cancer Centers of the Desert, Palm Springs

Desert Hematology Oncology Medical Group INC, Rancho Mirage

Scripps Cancer Center, La Jolla

Oregon Health & Science University, Portland

Swedish Cancer Institute, Seattle

Yakima Regional CancerCenter, Yakima

Whittingham Cancer Center, Norwalk

VA Connecticut Healthcare System, West Haven

Hematology Oncology Associates of NJ, Paramus

Summit Medical Group/Overlook Oncology Center, Summit

Wake Forest Univ School of Medicine, Winston-Salem